Figure][1] T heranostics , or radiotheranostics , is a term that describes how the same radiopharmaceutical can be used for ...

The poly (adenosine diphosphate–ribose)polymerase (PARP) family of enzymes is an important factor in the cellular DNA damage response and has gained much attention for its role in many diseases, ...

We aimed to systematically determine the impact of tumor burden on 68Ga-prostate-specific membrane antigen-11 (68Ga-PSMA) PET biodistribution by the use of quantitative measurements. Methods: This ...

Nectin-4 is an overexpressed biomarker in 60%–70% of triple-negative breast cancer (TNBC) cases and an ideal target for radiotherapy and PET imaging. In this study, theranostic radioimmunoconjugates ...

PET is a powerful molecular imaging technique that can provide functional information on living objects. However, the spatial resolution of PET imaging has been limited to around 1 mm, which makes it ...

Actinomycosis is a rare gram-positive infection, generally granulomatous. The diagnosis can be complex and sometimes can be achieved only at the chronic stage. Actinomyces normally colonize the mouth, ...

High expression of prostate-specific membrane antigen (PSMA) is not limited to prostate cancer but can be found in other tumor entities, such as hepatocellular carcinoma (HCC), and could possibly be ...

Personalization of treatment response through the use of on-treatment biomarkers is the future of theranostics and marks a key advantage of theranostics treatments over other systemic cancer therapies ...

The most recent survey (1) related to α-radiotherapy development showed that 27 molecules labeled with 225 Ac are presently under development, among which 13 have already reached human test level. The ...

A semiquantitative scoring system was used to quantify the severity and frequency of hypoglycemic episodes under background antihypoglycemic therapy (somatostatin analogs, diazoxide, everolimus, or ...

Journal of Nuclear Medicine April 2026, jnumed.125.271421; DOI: https://doi.org/10.2967/jnumed.125.271421 ...

Small cell lung cancer (SCLC) is an aggressive malignancy associated with a poor prognosis and early treatment resistance (1). Despite multimodal therapy regimens including chemotherapy, external ...